Drug Type Universal CAR-T |
Synonyms Anti-CD5 γδ CAR-T(Curocell) |
Target |
Action inhibitors |
Mechanism T-cell surface glycoprotein CD5 inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoma | Preclinical | South Korea | 18 Apr 2023 |